Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals

BACKGROUND: A SARS-CoV-2+Flu A/B+RSV Combo Rapid test may be more relevant than Rapid Antigen Diagnostic (RAD) tests targeting only SARS-CoV-2 since we are facing a concurrent circulation of these viruses during the winter season. OBJECTIVES: To assess the clinical performance of a SARS-CoV-2+Flu A/...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayart, Jean-Louis, Gillot, Constant, Dogné, Jean-Michel, Roussel, Gatien, Verbelen, Valérie, Favresse, Julien, Douxfils, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970915/
https://www.ncbi.nlm.nih.gov/pubmed/36905798
http://dx.doi.org/10.1016/j.jcv.2023.105419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970915/
https://www.ncbi.nlm.nih.gov/pubmed/36905798
http://dx.doi.org/10.1016/j.jcv.2023.105419

Ejemplares similares